Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.69 INR | -6.62% |
|
-5.92% | -29.39% |
05-25 | Trident Texofab Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
02-15 | Trident Texofab's CFO Resigns | MT |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 503.3 | 392 | 414 | 259.3 | 623.3 | 579.4 |
Enterprise Value (EV) 1 | 551.3 | 534.8 | 642.5 | 612 | 1,029 | 959.4 |
P/E ratio | 67.1 x | 31 x | 48.2 x | 73.6 x | 63.4 x | 26.2 x |
Yield | 0.79% | 1.02% | - | - | - | - |
Capitalization / Revenue | 0.59 x | 0.45 x | 0.46 x | 0.52 x | 0.74 x | 0.6 x |
EV / Revenue | 0.65 x | 0.62 x | 0.71 x | 1.23 x | 1.22 x | 1 x |
EV / EBITDA | 37.9 x | 22.4 x | 14.1 x | 20.1 x | 17.7 x | 11.9 x |
EV / FCF | -16.8 x | -4.4 x | -8.15 x | -7.07 x | -16.8 x | 52.8 x |
FCF Yield | -5.94% | -22.7% | -12.3% | -14.1% | -5.96% | 1.9% |
Price to Book | 6.09 x | 3.63 x | 3.55 x | 2.17 x | 4.81 x | 3.82 x |
Nbr of stocks (in thousands) | 9,590 | 9,590 | 9,590 | 10,070 | 10,070 | 10,070 |
Reference price 2 | 52.48 | 40.88 | 43.17 | 25.75 | 61.90 | 57.54 |
Announcement Date | 13/07/18 | 03/07/19 | 27/08/20 | 25/08/21 | 31/08/22 | 28/08/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 854.6 | 869 | 909.6 | 499.3 | 842.9 | 963.6 |
EBITDA 1 | 14.53 | 23.89 | 45.59 | 30.47 | 58.21 | 80.81 |
EBIT 1 | 13.27 | 20.85 | 37.54 | 22.11 | 45.31 | 65.66 |
Operating Margin | 1.55% | 2.4% | 4.13% | 4.43% | 5.38% | 6.81% |
Earnings before Tax (EBT) 1 | 10.37 | 16.9 | 13.46 | 9.043 | 12.73 | 27.26 |
Net income 1 | 7.5 | 12.74 | 8.589 | 3.532 | 9.827 | 22.18 |
Net margin | 0.88% | 1.47% | 0.94% | 0.71% | 1.17% | 2.3% |
EPS 2 | 0.7821 | 1.317 | 0.8956 | 0.3500 | 0.9759 | 2.200 |
Free Cash Flow 1 | -32.73 | -121.5 | -78.82 | -86.6 | -61.3 | 18.19 |
FCF margin | -3.83% | -13.98% | -8.66% | -17.34% | -7.27% | 1.89% |
FCF Conversion (EBITDA) | - | - | - | - | - | 22.51% |
FCF Conversion (Net income) | - | - | - | - | - | 81.98% |
Dividend per Share 2 | 0.4167 | 0.4167 | - | - | - | - |
Announcement Date | 13/07/18 | 03/07/19 | 27/08/20 | 25/08/21 | 31/08/22 | 28/08/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 48 | 143 | 228 | 353 | 406 | 380 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 3.303 x | 5.979 x | 5.012 x | 11.58 x | 6.974 x | 4.702 x |
Free Cash Flow 1 | -32.7 | -121 | -78.8 | -86.6 | -61.3 | 18.2 |
ROE (net income / shareholders' equity) | 12.4% | 13.2% | 7.52% | 2.99% | 7.88% | 15.8% |
ROA (Net income/ Total Assets) | 2.39% | 2.77% | 4.72% | 2.24% | 4.08% | 5.53% |
Assets 1 | 313.9 | 459.8 | 181.9 | 157.7 | 240.8 | 400.8 |
Book Value Per Share 2 | 8.620 | 11.30 | 12.20 | 11.90 | 12.90 | 15.10 |
Cash Flow per Share 2 | 0.2400 | 0.4800 | 0.0900 | 0.0300 | 0.0400 | 0.0600 |
Capex 1 | 4.37 | 77 | 17.1 | 99.2 | 41.6 | 2.17 |
Capex / Sales | 0.51% | 8.86% | 1.88% | 19.86% | 4.93% | 0.22% |
Announcement Date | 13/07/18 | 03/07/19 | 27/08/20 | 25/08/21 | 31/08/22 | 28/08/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-29.39% | 5.78M | |
+20.42% | 7.24B | |
+6.95% | 3.63B | |
+69.62% | 2.37B | |
+4.90% | 2.28B | |
+6.07% | 2.23B | |
+15.23% | 2.22B | |
+5.68% | 1.77B | |
+30.77% | 1.65B | |
+2.33% | 1.63B |
- Stock Market
- Equities
- TTFL6 Stock
- Financials Trident Texofab Limited